Photofrin
information and resources from the National Cancer Institute
NCI Thesaurus | Photofrin
(Other name for: porfimer sodium)NCI Thesaurus | Photofrin
(Other name for: porfimer sodium)
porfimer sodium
For use in photodynamic therapy (PDT) for palliation of patients with completely obstructing esophageal cancer, or patients with partially obstructing esophageal cancer who cannot be satisfactorily treated with ND-YAG laser therapy.
QLT Phototherapeutics Inc. Dec 27 1995
porfimer sodium
For use in photodynamic therapy (PDT) for reduction of obstruction and palliation of symptoms in patients with completely or partially obstructing endobroncial nonsmall cell lung cancer (NSCLC).
QLT Phototherapeutics Inc. Dec 22 1998
porfimer sodium
For use in photodynamic therapy for treatment of microinvasive endobronchial nonsmall cell lung cancer in patients for whom surgery and radiotherapy are not indicated.
QLT Phototherapeutics Inc. Jan 09 1998
|
|
|
|
news articles
PDT kills drug-resistant bacteria Mar 23, 2006
University at Buffalo Reporter, The drug Photofrin® has been approved by the FDA as a sensitizer for PDT in the treatment of early and late stage endobronchial and esophageal cancers, as ...
Photodynamic therapy may be an effective treatment for infections ... Mar 13, 2006
News-Medical.net, ...chest wall. The drug Photofrin. has ... stomach lining. In the current research, after adding the light-sensitive drug Photofrin. to ...
Half a billion in cash, but what to do with it? Mar 25, 2006
Globe and Mail, ...it was going to create a lot of opportunities in the oncology space,� said another source familiar with QLT's first photodynamic drug, Photofrin, used to ...
HALF A BILLION IN CASH, BUT WHAT TO DO WITH IT? Mar 25, 2006
Globe and Mail, ...it was going to create a lot of opportunities in the oncology space," said another source familiar with QLT's first photodynamic drug, Photofrin, used to treat ...
After cancer scare, he savors meals Mar 14, 2006
The News Journal, ...option known as photodynamic therapy. In the procedure, a chemical called Photofrin is injected into the body. It lingers in high ...
QLT announces repositioning and streamlining for future growth Dec 8, 2005
Biotech Intelligence (press release), ...of the drug development function at QLT to be a core competency for the company that delivered several successful approvals for both Photofrin in oncology, and ...
|
|
